Sanara MedTech Inc. (SMTI)
NASDAQ: SMTI · Real-Time Price · USD
24.50
-0.70 (-2.78%)
Dec 17, 2025, 1:27 PM EST - Market open
Sanara MedTech Revenue
Sanara MedTech had revenue of $26.33M in the quarter ending September 30, 2025, with 21.51% growth. This brings the company's revenue in the last twelve months to $101.90M, up 30.55% year-over-year. In the year 2024, Sanara MedTech had annual revenue of $86.67M with 33.36% growth.
Revenue (ttm)
$101.90M
Revenue Growth
+30.55%
P/S Ratio
2.12
Revenue / Employee
$722,536
Employees
141
Market Cap
218.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 86.67M | 21.68M | 33.36% |
| Dec 31, 2023 | 64.99M | 19.15M | 41.77% |
| Dec 31, 2022 | 45.84M | 21.70M | 89.87% |
| Dec 31, 2021 | 24.14M | 8.56M | 54.90% |
| Dec 31, 2020 | 15.59M | 3.82M | 32.47% |
| Dec 31, 2019 | 11.77M | 5.93M | 101.56% |
| Dec 31, 2018 | 5.84M | -466.90K | -7.41% |
| Sep 30, 2018 | 6.30M | - | - |
| Dec 31, 2017 | 6.30M | 796.89K | 14.47% |
| Dec 31, 2016 | 5.51M | 2.14M | 63.33% |
| Dec 31, 2015 | 3.37M | 739.55K | 28.09% |
| Dec 31, 2014 | 2.63M | 906.25K | 52.49% |
| Dec 31, 2013 | 1.73M | 552.85K | 47.11% |
| Dec 31, 2012 | 1.17M | -1.04M | -46.89% |
| Dec 31, 2011 | 2.21M | 1.30M | 142.71% |
| Dec 31, 2010 | 910.42K | 622.40K | 216.10% |
| Dec 31, 2009 | 288.02K | -2.16K | -0.75% |
| Dec 31, 2008 | 290.18K | -340.32K | -53.98% |
| Dec 31, 2007 | 630.51K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
SMTI News
- 7 days ago - Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™ - GlobeNewsWire
- 20 days ago - Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps - Seeking Alpha
- 4 weeks ago - Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd - GlobeNewsWire
- 5 weeks ago - Sanara MedTech Inc. (SMTI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited) - GlobeNewsWire
- 5 weeks ago - Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business - GlobeNewsWire
- 2 months ago - Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025 - GlobeNewsWire
- 3 months ago - Sanara MedTech: Growth Remains Strong As Debt Concerns Recede - Seeking Alpha